Literature DB >> 1615128

Sensitization to haloperidol-induced suppression of milk intake: effect of interdose interval.

D L Wolgin1, J Moore.   

Abstract

The purpose of this study was to determine the effect of manipulating the interdose interval (IDI) on the suppression of milk intake induced by haloperidol (HAL). Groups of rats were given chronic injections of either HAL (0.625 mg/kg) or saline at IDIs of 1, 2, 7, or 14 days. Dose-response curves were determined at the conclusion of the chronic phase. The results indicated that injections of HAL given at IDIs of 1 or 2 days produced neither tolerance nor sensitization, whereas injections given at intervals of 7 or 14 days produced sensitization. Sensitization was also observed in the control groups, perhaps as a result of the intermittent schedule of HAL injections given during the dose-response tests. Sensitization to HAL was not accompanied by changes in sensitivity to amphetamine. The results of this experiment are consistent with those of other studies in showing that the behavioral effects of neuroleptics are strongly influenced by the schedule of injections. In addition, evidence is presented that sensitization to HAL-induced hypophagia is contingent on behavioral experience under the drug.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1615128     DOI: 10.1007/bf02245150

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  Behavioral effects of a single neuroleptic treatment grow with the passage of time.

Authors:  S M Antelman; D Kocan; D J Edwards; S Knopf; J M Perel; R Stiller
Journal:  Brain Res       Date:  1986-10-15       Impact factor: 3.252

2.  Contingent tolerance to the anorexigenic effects of amphetamine.

Authors:  P L Carlton; D L Wolgin
Journal:  Physiol Behav       Date:  1971-08

3.  The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity.

Authors:  K J Dewey; H C Fibiger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

4.  The effect of drug holidays in an animal model of tardive dyskinesia.

Authors:  J Bannet; R H Belmaker; R P Ebstein
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

5.  An examination of methodological refinements, clozapine and fluphenazine in the anhedonia paradigm.

Authors:  W O Faustman; S C Fowler
Journal:  Pharmacol Biochem Behav       Date:  1982-11       Impact factor: 3.533

6.  Differential attenuation of water intake and water-rewarded operant responding by repeated administration of haloperidol and SCH 23390 in the rat.

Authors:  T Ljungberg
Journal:  Pharmacol Biochem Behav       Date:  1990-01       Impact factor: 3.533

7.  Treatment schedule as a determinant of the development of tolerance to haloperidol.

Authors:  R J Carey; J DeVeaugh-Geiss
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Some effects of pimozide on nondeprived rats' lever pressing maintained by a sucrose reward in an anhedonia paradigm.

Authors:  S E Gramling; S C Fowler; J P Tizzano
Journal:  Pharmacol Biochem Behav       Date:  1987-05       Impact factor: 3.533

9.  Contingent suppression of tolerance to haloperidol: a dose-response analysis.

Authors:  D L Wolgin
Journal:  Pharmacol Biochem Behav       Date:  1990-02       Impact factor: 3.533

10.  Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food.

Authors:  R A Wise; J Spindler; H deWit; G J Gerberg
Journal:  Science       Date:  1978-07-21       Impact factor: 47.728

View more
  2 in total

1.  Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.

Authors:  Jun Gao; Ming Li
Journal:  Behav Brain Res       Date:  2013-10-05       Impact factor: 3.332

Review 2.  Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms.

Authors:  Ming Li
Journal:  J Psychopharmacol       Date:  2016-07-01       Impact factor: 4.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.